Profile
David Burke currently works at The Ruth Group, Inc., as Vice President, The IGB Group, as Vice President, and Sernova Biotherapeutics, Inc., as Vice President-Investor Relations from 2024.
Mr. Burke also formerly worked at Albemarle Corp., as Director-Investor Relations from 2021 to 2022, Rigel Pharmaceuticals, Inc., as Director-Investor Relations & Communications from 2018 to 2021, Dynavax Technologies Corp., as Director-IR & Corporate Communications from 2018 to 2019, and Aldeyra Therapeutics, Inc., as Head-Investor Relations.
Mr. Burke received his undergraduate degree from the University of North Carolina at Chapel Hill.
David Burke active positions
| Companies | Position | Start |
|---|---|---|
| SERNOVA BIOTHERAPEUTICS INC | Investor Relations Contact | 10/10/2024 |
The IGB Group
The IGB Group Miscellaneous Commercial ServicesCommercial Services Operates as an independent investor relations, advisory and strategic communications firm | President | - |
The Ruth Group, Inc.
The Ruth Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides investor and public relations services | Corporate Officer/Principal | - |
Former positions of David Burke
| Companies | Position | End |
|---|---|---|
| ALBEMARLE CORPORATION | Investor Relations Contact | 30/04/2022 |
| RIGEL PHARMACEUTICALS, INC. | Investor Relations Contact | 31/12/2020 |
| DYNAVAX TECHNOLOGIES CORPORATION | Investor Relations Contact | 28/01/2019 |
| ALDEYRA THERAPEUTICS, INC. | Investor Relations Contact | - |
Training of David Burke
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Albemarle Corp.
Albemarle Corp. Chemicals: SpecialtyProcess Industries Manufactures basic lithium compounds for energy storage, plastic materials and organometallic co-catalysts | Process Industries |
Rigel Pharmaceuticals, Inc.
Rigel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which discovers, develops and provides novel small-molecule drugs | Health Technology |
Dynavax Technologies Corp.
Dynavax Technologies Corp. BiotechnologyHealth Technology Develops and commercializes novel products to prevent and treat infectious diseases | Health Technology |
Sernova Biotherapeutics, Inc.
Sernova Biotherapeutics, Inc. BiotechnologyHealth Technology Develops life science products | Health Technology |
Aldeyra Therapeutics, Inc.
Aldeyra Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for eye diseases | Health Technology |
The Ruth Group, Inc.
The Ruth Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides investor and public relations services | Commercial Services |
The IGB Group
The IGB Group Miscellaneous Commercial ServicesCommercial Services Operates as an independent investor relations, advisory and strategic communications firm | Commercial Services |
University of North Carolina at Chapel Hill
University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- David Burke
















